Cargando…
Value added medicines: what value repurposed medicines might bring to society?
Background & objectives: Despite the wide interest surrounding drug repurposing, no common terminology has been yet agreed for these products and their full potential value is not always recognised and rewarded, creating a disincentive for further development. The objectives of the present study...
Autores principales: | Toumi, Mondher, Rémuzat, Cécile |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Routledge
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5328340/ https://www.ncbi.nlm.nih.gov/pubmed/28265347 http://dx.doi.org/10.1080/20016689.2017.1264717 |
Ejemplares similares
-
Advanced therapy medicinal products: current and future perspectives
por: Hanna, Eve, et al.
Publicado: (2016) -
Risk of discontinuation of Advanced Therapy Medicinal Products clinical trials
por: Hanna, Eve, et al.
Publicado: (2016) -
New drug regulations in France: what are the impacts on market access? Part 1 – Overview of new drug regulations in France
por: Rémuzat, Cécile, et al.
Publicado: (2013) -
New drug regulations in France: what are the impacts on market access? Part 2 – impacts on market access and impacts for the pharmaceutical industry
por: Rémuzat, Cécile, et al.
Publicado: (2013) -
Market access pathways for cell therapies in France
por: Rémuzat, Cécile, et al.
Publicado: (2015)